MedTrace Logo

Screening Method in Sacral Neuromodulation

NCT01130415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2010-05-26

No results posted yet for this study

Summary

The purpose of this study was to evaluate whether there is a difference in long-term outcome between patients screened with the percutaneous nerve evaluation (PNE) and first stage tined lead procedure (TLP).

Conditions

Sponsors & Collaborators

  • Scientific Foundation Urology Maastricht

    collaborator UNKNOWN

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Philip van Kerrebroeck, Prof · Maastricht University Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2009-05-31
Completion
2009-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01130415 on ClinicalTrials.gov